Latest AI and machine learning research in dementia for healthcare professionals.
Early detection of cognitive impairment in assisted living is hindered by time-intensive tools like the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA). We present a 60-second voice-based screening model that analyzes picture descriptions to estimate dementia risk. While recent deep learning approaches have shown promise on similar tasks, their lack of interpretab...
BACKGROUND: AI-enabled chatbots and related conversational systems can facilitate human-computer interaction through natural language, personalization, and automated support. In pediatric health promotion, these tools have the potential to provide scalable and flexible approaches to support physical activity (PA) and related lifestyle behavior change within family contexts. However, evidence regar...
BACKGROUND: Generative artificial intelligence (GenAI) tools are widely accessible to the public, who are engaging with them for a wide range of healt...
BACKGROUND AND PURPOSE: Frontotemporal dementia (FTD) is characterized by frontal and anterior temporal lobe atrophy and progressive changes in behavi...
OBJECTIVES: Building on innovations for autism detection-where artificial intelligence (AI)-based models monitor clinical data within electronic healt...
BackgroundAccurate quantification of standardized uptake value ratio (SUVR) in amyloid PET is essential for Alzheimer's disease (AD) diagnosis but typ...
BACKGROUND AND OBJECTIVES: To examine the ethical considerations related to artificial intelligence technologies in dementia across diagnostic, manage...
Alzheimer's disease (AD) disrupts brain function through cell type-specific transcriptomic and epigenomic alterations, yet the contribution of three-d...
This article offers a comprehensive analysis of the representations of nursing and healthcare in contemporary and classic dystopian literature and fil...
Sleep-wake disturbances commonly occur in Alzheimer's disease (AD). However, the precise mechanisms underlying the breakdown of the circadian gene net...
BACKGROUND: Enlarged perivascular spaces (ePVS) are a marker of cerebral small vessel disease, potentially reflecting reduced waste clearance. Because...
BackgroundAccurate, non-invasive prediction of cerebral amyloid-β (Aβ) pathology in mild cognitive impairment (MCI) remains challenging yet critical f...
PURPOSE: Early detection of cognitive decline is essential for timely diagnosis and treatment. This study aimed to evaluate whether upper-limb movemen...
Predicting the risk of Alzheimer's disease (AD) is fundamental for early-stage intervention. Nevertheless, most methods struggle to extract multi-omic...
Examining sleep patterns in relation to chronological ageing and dementia can provide insights for risk screening. Integrating predictive models with ...
Histological analysis is essential for understanding disease pathology and the microenvironment, particularly in Alzheimer's disease (AD), characteriz...
Apoptosis and pyroptosis-mediated neuronal death represent major pathogenic mechanisms underlying Alzheimer's disease (AD). Given the potential crosst...
BACKGROUND: Distinguishing individuals with cognitive decline (CD), including early Alzheimer's disease, from cognitively normal (CN) individuals is e...
Alzheimer's disease (AD) is a complex neurodegenerative disorder which is multifactorial in nature. Some of its characteristics are slow cognitive dec...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder, with mild cognitive impairment (MCI) as its prodromal stage. Accurate MCI conver...